For a small biotech looking to make the jump into running its first clinical trial, the right CRO can be crucial to success.
The question of what early-stage drug developers should look for in a vendor was answered by Scott Sawicki, senior director of strategic sourcing and vendor management at Centessa Pharmaceuticals. Now under the Eli Lilly umbrella since Centessa’s acquisition in June 2026, Sawicki brought his experience from big pharma and innovative biotech, as well as working within CROs, to discuss the opportunities and pitfalls companies face in outsourcing clinical work for the first time.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Sawicki explored these topics in a Q&A session with Clinical Trials Arena reporter Frankie Fattorini at the 2026 Outsourcing in Clinical Trials New England conference, held 27–28 October in Boston, Massachusetts.
You can listen to more podcasts from the GlobalData Media Healthcare team here. GlobalData is the parent company of Clinical Trials Arena.
